CENOBAMATE — all Canadian products
11 DINs
11 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CENOBAMATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02538792 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet; Kit | Oral | CENOBAMATE 150 MG; CENOBAMATE 200 MG | Approved | |
| 02538652 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet | Oral | CENOBAMATE 12.5 MG | Marketed | |
| 02538660 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet | Oral | CENOBAMATE 25 MG | Marketed | |
| 02538725 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet | Oral | CENOBAMATE 50 MG | Marketed | |
| 02538733 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet | Oral | CENOBAMATE 100 MG | Marketed | |
| 02538741 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet | Oral | CENOBAMATE 150 MG | Marketed | |
| 02538768 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet | Oral | CENOBAMATE 200 MG | Marketed | |
| 02538776 | XCOPRI | KNIGHT THERAPEUTICS INC. | Kit; Tablet | Oral | CENOBAMATE 12.5 MG; CENOBAMATE 25 MG | Marketed | |
| 02538784 | XCOPRI | KNIGHT THERAPEUTICS INC. | Kit; Tablet | Oral | CENOBAMATE 50 MG; CENOBAMATE 100 MG | Marketed | |
| 02538806 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet; Kit | Oral | CENOBAMATE 100 MG; CENOBAMATE 150 MG | Approved | |
| 02538814 | XCOPRI | KNIGHT THERAPEUTICS INC. | Tablet; Kit | Oral | CENOBAMATE 150 MG; CENOBAMATE 200 MG | Approved |
Browse other molecules: